Give long acting inhaled BD combo LABA LAMA plus short acting rescue BD inhaled is preferred vs oral A Add ICS if blood eos 300 LABA ICS not recommended LABAs and LAMAs improve dyspnea reduce exac rate A LAMAs reduce exac A and hospitalizations B more tha

By rray, 22 February, 2024
Exclude Patient Type Detail Header
No
Footnote
<sup>1</sup> <b>Brief cessation counseling:</b><br>
• <b>Ask</b> tobacco users about tobacco use at every visit; use office-wide identification system.<br>
• <b>Advise</b> quitting, in a clear, strong, personalized manner.<br>
• <b>Assess</b> willingness to quit, determine when (e.g., w/in next 30 days).<br>
• <b>Assist</b> w/ quit plan, including practical counseling, exploring social support, prescribing pharm tx, educational resources.<br>
• <b>Arrange</b> f/u in person or via phone, etc.
Detail Type
Text
Detail Text
Rescue short acting BD SABA or SAMA for immediate sx relief SABA options albuterol levalbuterol MDI NEB SAMA ipratropium MDI NEB
LABA LAMA nbsp nbsp LABA options arformoterol formoterol olodaterol salmeterol nbsp nbsp LAMA options aclidinium glycopyrrolate revefenacin tiotropium DPI MDI umeclidinium nbsp nbsp LAMA LABA combo options aclidinium formoterol glycopyrrolate formoterol t
Patient Type Detail Header (Long)
<b>Give long-acting inhaled BD combo (LABA+LAMA) plus short-acting rescue BD; inhaled is preferred vs. oral [A]. Add ICS if blood eos ≥300. LABA+ICS not recommended.</b> LABAs and LAMAs improve dyspnea, reduce exac rate [A]. LAMAs reduce exac [A]and hospitalizations [B]more than LABAs; combos more effective than mono-tx [B]. Tailor choice of inhaler to pt’s ability and preference. Single-inhaler tx may be more effective/convenient than multiple inhalers and improves compliance.